Celgene Partnering Deals and Alliances 2010-2016 - Partnering Activity of One of the World's Leading Life Sciences Companies - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Celgene Partnering Deals and Alliances 2010 to 2016" company profile to their offering.

The Celgene Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies.

One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.

Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company's business development objectives.

Analyzing actual company agreements allows assessment of the following:

- What is actually granted by the agreement to the partner company?

- What exclusivity is granted?

- What is the payment structure for the deal?

- How are sales and payments audited?

- What is the deal term?

- How are the key terms of the agreement defined?

- How are IPRs handled and owned?

- Who is responsible for commercialization?

- Who is responsible for development, supply, and manufacture?

- How is confidentiality and publication managed?

- How are disputes to be resolved?

- Under what conditions can the deal be terminated?

- What happens when there is a change of ownership?

- What sublicensing and sub-contracting provisions have been agreed?

- Which boilerplate clauses does the company insist upon?

- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

- Which jurisdiction does the company insist upon for agreement law?

Partnering Deals and Alliances since 2010 report provides the user with the following key benefits:

- Partnering interests and therapy focus revealed

- Partnering activity since 2010 - number of deals per year

- Partnering activity for 2010-present

- Activity by deal type

- Activity by phase of development

- Activity by therapeutic area

- List of recent partner companies

- Detailed listing of all partnering deals since 2010

- Comprehensive access to actual contracts entered into by the company and its partners*

- Insight into the terms included in a partnering agreement

- Understand the key deal terms the company has agreed in previous deals

- Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Most active partner companies

Chapter 3 - Top deals by value

Chapter 4 - Submitting Opportunities

Chapter 5 - Forthcoming partnering events

Chapter 6 - Partnering and M&A directory since 2010

For more information visit http://www.researchandmarkets.com/research/45kfbc/celgene

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Company Reports

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Company Reports